FDA Warns Online Vendors to Stop Selling Unapproved Weight-Loss Drugs
The FDA on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide.
Related Articles
Medscape on LinkedIn: Join us for a symposium on ulcerative colitis (UC) designed to encourage…
Join us for a symposium on ulcerative colitis (UC) designed to encourage the exchange of ideas between leaders in the field and attendees. This event…
Hyperparathyroidism: Diagnosis, Assessment, and Management
This Guidelines summary covers diagnostics, monitoring, care in pregnancy, and advice for patients with primary hyperparathyroidism
Measles Outbreak: Vital Updates for Your Practice
Measles resurgence threatens global health, with rising cases and travel-related risks. Experts discuss the outbreak’s impact on healthcare.
HIV: Testing Uptake
A concise summary of the NICE and PHE guidance on increasing the uptake of HIV testing
Delta Wave Sleep Disruption Linked to Increased CV Risk
Delta wave activity disruption during sleep may be a useful metric to identify those at an increased risk for cardiovascular disease and mortality, a new…
Is Nighttime the Best Time for Exercise?
The timing of moderate to vigorous physical activity was associated with a lower risk for mortality and CVD in adults with obesity, including those with…
Atrial Shunt Echo Results Hint at Why Only Some Respond
Echo findings in heart failure patients with preserved or mildly reduced ejection fraction treated with an atrial shunt shed light on why only certain patients…
Topics Cardiologists Love to Hate: MOC and AI
Bob Harrington and Mike Gibson discuss two of the hottest topics in cardiology and medicine for 2023: a proposed alternative to the maintenance of certification…
Osteoporosis: Assessing Risk of Fragility Fracture
This NICE guideline summary discusses risk assessment for fragility fracture in osteoporosis
Is Nighttime the Best Time for Exercise?
The timing of moderate to vigorous physical activity was associated with a lower risk for mortality and CVD in adults with obesity, including those with…